AT1 Receptors in Renal Microvascular Physiology

AT1 受体在肾微血管生理学中的作用

• 批准号: 6833290
• 负责人: Lisa M. Harrison-Bernard
• 金额: $ 22.33万
• 依托单位: LSU HEALTH SCIENCES CENTER
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2007-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6833290
• 关键词: ACE inhibitors; angiotensin II; angiotensin receptor; dietary sodium; hemodynamics; kidney circulation; kidney function; laboratory mouse; microcirculation; nitric oxide; nitric oxide synthase; nutrition related tag; protein isoforms; protein localization

DESCRIPTION (provided by applicant): Angiotensin (Ang) II has powerful effects on the kidney which are mediated primarily by the AT1 receptor. There are 2 unique AT1 receptor subtypes in rodents, AT1A and AT1B, which cannot be distinguished using pharmacological antagonists. Accordingly, the long term goal of this project is to determine the contribution of AT1A and AT1B receptors in mediating AnglI actions on renal microvascular function. The overall hypothesis to be tested is that the distribution of the AT1 A and AT1 B receptors along the renal microvasculature is not uniform; afferent arterioles have both AT1A and AT1 B subtypes, whereas effereni arterioles have only the AT1A receptor subtype. Therefore, the compensatory functions of the AT1A and AT1B receptors are restricted to the preglomerular vasculature. The hypothesis will be tested in the following specific aims: 1) To map the distribution of the ATIA and ATIB receptors on the pre- and postglomerular vasculature; 2) To elucidate the mechanism of calcium signaling evoked by activation of afferent and efferent arteriolar AT1A and AT1B receptors; 3) To determine the changes in microvascular AT1A and AT1B receptor expression and function in response to alterations in circulating Angli levels; and 4) To examine the functional consequences of renal microvascular AT1 receptor absence on the activity of counterregulatory vasodilatory actions of nitric oxide (NO) derived from neuronal (nNOS) and/or endothelial (eNOS) nitric oxide synthases. Mice with targeted disruption of AT1A and/or AT1B receptors will be studied to discern the functions of the AT1 receptor subtypes. Angli responses will be determined by direct visualization of preglomerular (arcuate, interlobular artery, afferent arteriole) and postglomerular (efferent arteriole, descending vasa recta) vasculature using the mouse in vitro blood perfused juxtamedullary nephron technique. Regulation of AT1 receptor subtype microvascular function and mRNA and protein expression/localization will be determined during chronically altered Angil levels mediated by varied salt intake, angiotensin converting enzyme inhibition, and Angil infusion. The interaction of AT1 receptors and NO derived from nNOS and eNOS on renal microvascular function will be evaluated by pharmacological approaches. The results of these studies will delineate the complex, overlapping, and distinct functions of AT1 receptors in controlling renal microvascular hemodvnamics.

描述（由申请人提供）：血管紧张素（Ang） II对肾脏有强大的作用，主要由AT1受体介导。在啮齿类动物中有两种独特的AT1受体亚型，AT1A和AT1B，无法用药物拮抗剂区分。因此，本项目的长期目标是确定AT1A和AT1B受体在介导AnglI对肾微血管功能的作用中的作用。待检验的总体假设是，at1a和at1b受体沿肾微血管的分布不均匀；传入小动脉有AT1A和at1b亚型，而传出小动脉只有AT1A受体亚型。因此，AT1A和AT1B受体的代偿功能仅限于肾小球前血管系统。该假设将在以下具体目标中进行检验：1)绘制肾小球前和肾小球后血管系统中ATIA和ATIB受体的分布；2)阐明传入和传出小动脉AT1A和AT1B受体激活引发钙信号的机制；3)测定微血管AT1A和AT1B受体表达和功能随循环Angli水平变化的变化；4)研究肾微血管AT1受体缺失对神经元（nNOS）和/或内皮（eNOS）一氧化氮合酶衍生的一氧化氮（NO）反调节血管扩张活性的功能影响。将对AT1A和/或AT1B受体靶向破坏的小鼠进行研究，以辨别AT1受体亚型的功能。Angli反应将通过直接可视化肾小球前（弓形、小叶间动脉、传入小动脉）和肾小球后（传出小动脉、降血管）血管系统来确定，该技术采用小鼠离体血灌注髓旁肾元技术。在不同盐摄入量、血管紧张素转换酶抑制和Angil输注介导的Angil水平长期改变过程中，AT1受体亚型微血管功能、mRNA和蛋白表达/定位的调节将被确定。AT1受体与nNOS和eNOS衍生的NO的相互作用对肾脏微血管功能的影响将通过药理学方法进行评估。这些研究的结果将描述AT1受体在控制肾脏微血管血流动力学中的复杂、重叠和独特的功能。